AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Connect Biopharma Holdings Limited Ordinary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00ZGYNJZ5
0.77▲ 0.00 (0.58%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
0.76
Day's Range
0.74 – 0.78
52-Week Range
0.73 – 3.82
Volume
341.2K
Avg Volume
7.4M
Share Statistics
Shares Outstanding
Employees
64
Exchange
XNAS
Listed
2025-09-03
Share count as of July 31, 2026

Connect Biopharma Holdings Limited Ordinary Shares (CNTB) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Connect Biopharma Holdings Limited Ordinary Shares (CNTB)
What is Connect Biopharma Holdings Limited Ordinary Shares's Market Cap?
Connect Biopharma Holdings Limited Ordinary Shares's Market Cap is $48.3M, based on as-reported figures from SEC (XBRL) filings.
What is Connect Biopharma Holdings Limited Ordinary Shares's Price / Sales?
Connect Biopharma Holdings Limited Ordinary Shares's Price / Sales is 16.3×, based on as-reported figures from SEC (XBRL) filings.
What is Connect Biopharma Holdings Limited Ordinary Shares's Revenue (TTM)?
Connect Biopharma Holdings Limited Ordinary Shares's Revenue (TTM) is $3.0M, based on as-reported figures from SEC (XBRL) filings.
What is Connect Biopharma Holdings Limited Ordinary Shares's Net Income (TTM)?
Connect Biopharma Holdings Limited Ordinary Shares's Net Income (TTM) is -$69.0M, based on as-reported figures from SEC (XBRL) filings.
What is Connect Biopharma Holdings Limited Ordinary Shares's EBITDA?
Connect Biopharma Holdings Limited Ordinary Shares's EBITDA is -$69.7M, based on as-reported figures from SEC (XBRL) filings.
What is Connect Biopharma Holdings Limited Ordinary Shares's Diluted EPS (TTM)?
Connect Biopharma Holdings Limited Ordinary Shares's Diluted EPS (TTM) is -1.10, based on as-reported figures from SEC (XBRL) filings.
What is Connect Biopharma Holdings Limited Ordinary Shares's EBITDA Margin?
Connect Biopharma Holdings Limited Ordinary Shares's EBITDA Margin is -2361.3%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CNTBAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024
License and collaboration revenues
YoY growth+5666.7%—-100.0%-98.7%
Operating expenses:
Research and development expense
General and administrative expense
Total operating expenses
% of revenue736.0%11701.8%—110581.3%
Loss from operations
% of revenue-636.0%-11601.8%—-110481.3%
Other income, net:
Interest income
Other income (expense)
Total other income, net
Net loss before income tax
Net loss
% of revenue-624.4%-11478.1%—-107500.0%
Basic net loss per ordinary share (in dollars per share)
Diluted net loss per ordinary share (in dollars per share)